Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nabiximols for spasticity in multiple sclerosis
NCT04203498Phase 3Terminated
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Oct 2020
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of cannabis extract in multiple sclerosis (MS), sponsored by Jazz Pharmaceuticals plc. Started Oct 2020; status: terminated.
02
Drugs
cannabis extract
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT04203498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04203498.